A clinical trial in a controlled setting to learn more about allergies caused by house dust

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001855-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the dose-related efficacy of MK-8237 sublingual house dust mite (HDM) tablet versus placebo in the treatment of HDM-induced rhinitis based on the average total nasal symptom score (TNSS) determined during the chamber challenge session at Week 24.


Critère d'inclusion

  • House Dust Induced Rhinitis/Rhinoconjunctivitis

Liens